335 related articles for article (PubMed ID: 19210946)
1. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
Goldberg JF; Brooks JO; Kurita K; Hoblyn JC; Ghaemi SN; Perlis RH; Miklowitz DJ; Ketter TA; Sachs GS; Thase ME
J Clin Psychiatry; 2009 Feb; 70(2):155-62. PubMed ID: 19210946
[TBL] [Abstract][Full Text] [Related]
2. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.
Marangell LB; Dennehy EB; Wisniewski SR; Bauer MS; Miyahara S; Allen MH; Martinez M; Al Jurdi RK; Thase ME
J Clin Psychiatry; 2008 Jun; 69(6):916-22. PubMed ID: 18399724
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
[TBL] [Abstract][Full Text] [Related]
5. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
6. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2007 Nov; 103(1-3):5-11. PubMed ID: 17628692
[TBL] [Abstract][Full Text] [Related]
7. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
Post RM; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Leverich GS; Luckenbaugh DA; Rowe M; Pizzarello S; Kupka RW; Grunze H; Nolen WA
J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
[TBL] [Abstract][Full Text] [Related]
8. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
9. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2007 Nov; 103(1-3):23-8. PubMed ID: 17604119
[TBL] [Abstract][Full Text] [Related]
10. [Bipolar disorders--how to recognize and treat them].
Grunze H; Sasse J; Forsthoff A; Bauer M
MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694
[TBL] [Abstract][Full Text] [Related]
11. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2003 Feb; 73(3):223-8. PubMed ID: 12547290
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
13. Polypharmacy and suicide attempts in bipolar disorder.
Gazalle FK; Hallal PC; Tramontina J; Rosa AR; Andreazza AC; Zanatto V; Santin A; Kapczinski F; Ceresér KM
Braz J Psychiatry; 2007 Mar; 29(1):35-8. PubMed ID: 17435926
[TBL] [Abstract][Full Text] [Related]
14. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
Möller HJ; Grunze H; Broich K
Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):1-16. PubMed ID: 16078087
[TBL] [Abstract][Full Text] [Related]
15. An analysis of the efficacy of treatments for bipolar depression.
Nierenberg AA
J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
[TBL] [Abstract][Full Text] [Related]
16. Medication use patterns and 2-year outcome in first-admission bipolar disorder with psychotic features.
Craig TJ; Grossman S; Mojtabai R; Gibson PJ; Lavelle J; Carlson GA; Bromet EJ
Bipolar Disord; 2004 Oct; 6(5):406-15. PubMed ID: 15383133
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
Simon NM; Otto MW; Weiss RD; Bauer MS; Miyahara S; Wisniewski SR; Thase ME; Kogan J; Frank E; Nierenberg AA; Calabrese JR; Sachs GS; Pollack MH;
J Clin Psychopharmacol; 2004 Oct; 24(5):512-20. PubMed ID: 15349007
[TBL] [Abstract][Full Text] [Related]
18. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
19. [Puzzling bipolar disorder].
Forsthoff A; Born C; Grunze H
MMW Fortschr Med; 2005 May; 147 Spec No 2():32-6. PubMed ID: 15968870
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of bipolar disorders].
Haffen E; Sechter D
Encephale; 2006 Sep; 32 Pt 2():S531-5. PubMed ID: 17099569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
